BioSpace News Archive

Browse BioSpace’s published news and press releases by year, month, and day.
247 Results
Year
Month
Day
  • Cansortium Inc. (“Cansortium” or the “Company”) (CSE: TIUM.U), (OTCQB: CNTMF) a vertically-integrated provider of premium-quality medical cannabis operating under the Fluent™ brand, today announced the appointment of Ontario pharmacist Roger Daher to its Board of Directors.
  • New York City, NY: April 13, 2020 – Published: The demand in the global endoscopic cold light source market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications. On the other hand, the absence of a predefined regulato
  • New York City, NY: April 13, 2020 – Published: The demand in the global energy based device in hyperhidrosis market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications. On the other hand, the absence of a predefined
  • New York City, NY: April 13, 2020 – Published: The demand in the global essential tremor treatment market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications. On the other hand, the absence of a predefined regulatory
  • New York City, NY: April 13, 2020 – Published: The demand in the global fucoxanthin market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications. On the other hand, the absence of a predefined regulatory framework is s
  • The demand in the global allergic rhinitis drugs market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications.
  • The demand in the global amifostine market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications.
  • The demand in the global anaesthesia conduction kits market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications.
  • New York City, NY: April 13, 2020 – Published: The demand in the global anti-smoking products market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications. On the other hand, the absence of a predefined regulatory fram
  • The demand in the global apixaban market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications.